Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
International Journal of Biological Macromolecules
|
April 4, 2019
Biocompatible carbon dots derived from κ-carrageenan and phenyl boronic acid for dual modality sensing platform of sugar and its anti-diabetic drug release behavior
Poushali Das, Priti Prasanna Maity, Sayan Ganguly, et al.
Biomacromolecules
|
December 8, 2020
Dual Functionalized Injectable Hybrid Extracellular Matrix Hydrogel for Burn Wounds
Kamakshi Bankoti, Arun Prabhu Rameshbabu, Sayanti Datta, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2022
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2
Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
The Journal of the Association of Physicians of India
|
July 11, 2024
Edema India: Executive Summary of Screening, Diagnosis, and Management of Edema
Girish Mathur, Gurpreet Singh Wander, Shashank R Joshi, et al.
PNAS Nexus
|
January 30, 2023
Targeting an evolutionarily conserved "E-L-L" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2
Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Journal of Medicinal Chemistry
|
January 4, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition
Mousumi Shyam, Harshita Verma, Gourab Bhattacharje, et al.
Oncogene
|
May 11, 2018
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
Aditya Parekh, Subhayan Das, Sheetal Parida, et al.
Journal of Medicinal Chemistry
|
November 12, 2019
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate
Vidya Ramdas, Rashmi Talwar, Moloy Banerjee, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
September 16, 2025
Telestroke Outcomes and Challenges in a Lower-Middle-Income Country: Experience from the Swasthya Ingit Telestroke Program of West Bengal, India
Arpan Dutta, Arnab Sarkar, Subhadeep Gupta, et al.
Journal of Medicinal Chemistry
|
May 6, 2020
Discovery of Potent, Selective, and State-Dependent Na<sub>V</sub>1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides
Vidya Ramdas, Rashmi Talwar, Vijay Kanoje, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
International Journal of Biological Macromolecules
|
April 4, 2019
Biocompatible carbon dots derived from κ-carrageenan and phenyl boronic acid for dual modality sensing platform of sugar and its anti-diabetic drug release behavior
Poushali Das, Priti Prasanna Maity, Sayan Ganguly, et al.
Biomacromolecules
|
December 8, 2020
Dual Functionalized Injectable Hybrid Extracellular Matrix Hydrogel for Burn Wounds
Kamakshi Bankoti, Arun Prabhu Rameshbabu, Sayanti Datta, et al.
Biorxiv : the Preprint Server for Biology
|
March 22, 2022
Targeting an evolutionarily conserved "E-L-L" motif in the spike protein to develop a small molecule fusion inhibitor against SARS-CoV-2
Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
The Journal of the Association of Physicians of India
|
July 11, 2024
Edema India: Executive Summary of Screening, Diagnosis, and Management of Edema
Girish Mathur, Gurpreet Singh Wander, Shashank R Joshi, et al.
PNAS Nexus
|
January 30, 2023
Targeting an evolutionarily conserved "E-L-L" motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2
Indrani Das Jana, Prabuddha Bhattacharya, Karthick Mayilsamy, et al.
Journal of Medicinal Chemistry
|
January 4, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition
Mousumi Shyam, Harshita Verma, Gourab Bhattacharje, et al.
Oncogene
|
May 11, 2018
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
Aditya Parekh, Subhayan Das, Sheetal Parida, et al.
Journal of Medicinal Chemistry
|
November 12, 2019
Discovery and Characterization of Potent Pan-Genotypic HCV NS5A Inhibitors Containing Novel Tricyclic Central Core Leading to Clinical Candidate
Vidya Ramdas, Rashmi Talwar, Moloy Banerjee, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
September 16, 2025
Telestroke Outcomes and Challenges in a Lower-Middle-Income Country: Experience from the Swasthya Ingit Telestroke Program of West Bengal, India
Arpan Dutta, Arnab Sarkar, Subhadeep Gupta, et al.
Journal of Medicinal Chemistry
|
May 6, 2020
Discovery of Potent, Selective, and State-Dependent Na<sub>V</sub>1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure-Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides
Vidya Ramdas, Rashmi Talwar, Vijay Kanoje, et al.
Page
of 15